Xue DW - Search Results

1

LINC00511/miRNA-143-3p Modulates Apoptosis and Malignant Phenotype of Bladder Carcinoma Cells via PCMT1.

Dong LM, Zhang XL, Mao MH, Li YP, Zhang XY, Xue DW, Liu YL. Dong LM, et al. Among authors: xue dw. Front Cell Dev Biol. 2021 Apr 9;9:650999. doi: 10.3389/fcell.2021.650999. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33898446 Free PMC article.

2

[Greenlight photoselective vaporization prostatectomy versus thulium laser vaporesection of the prostate for aged high-risk BPH patients with the prostate heavier than 80 g].

Liu CL, Xue DW, Liu YL, Wang P. Liu CL, et al. Among authors: xue dw. Zhonghua Nan Ke Xue. 2011 May;17(5):431-4. Zhonghua Nan Ke Xue. 2011. PMID: 21837954 Clinical Trial. Chinese.

3

Endoscopic realignment in the management of complete transected ureter.

Liu C, Zhang X, Xue D, Liu Y, Wang P. Liu C, et al. Int Urol Nephrol. 2014 Feb;46(2):335-40. doi: 10.1007/s11255-013-0535-7. Epub 2013 Aug 8. Int Urol Nephrol. 2014. PMID: 23925502

4

Clinical significance and biological roles of TRIM24 in human bladder carcinoma.

Xue D, Zhang X, Zhang X, Liu J, Li N, Liu C, Liu Y, Wang P. Xue D, et al. Tumour Biol. 2015 Sep;36(9):6849-55. doi: 10.1007/s13277-015-3393-3. Epub 2015 Apr 7. Tumour Biol. 2015. PMID: 25846736

5

Rab27A overexpression promotes bladder cancer proliferation and chemoresistance through regulation of NF-κB signaling.

Liu J, Gong X, Zhu X, Xue D, Liu Y, Wang P. Liu J, et al. Oncotarget. 2017 Sep 8;8(43):75272-75283. doi: 10.18632/oncotarget.20775. eCollection 2017 Sep 26. Oncotarget. 2017. PMID: 29088864 Free PMC article.

6

PCMT1 is an unfavorable predictor and functions as an oncogene in bladder cancer.

Dong L, Li Y, Xue D, Liu Y. Dong L, et al. IUBMB Life. 2018 Apr;70(4):291-299. doi: 10.1002/iub.1717. Epub 2018 Mar 8. IUBMB Life. 2018. PMID: 29517839 Free article.

7

LncRNA TINCR is associated with clinical progression and serves as tumor suppressive role in prostate cancer.

Dong L, Ding H, Li Y, Xue D, Liu Y. Dong L, et al. Cancer Manag Res. 2018 Aug 20;10:2799-2807. doi: 10.2147/CMAR.S170526. eCollection 2018. Cancer Manag Res. 2018. PMID: 30154672 Free PMC article.

8

TRIP13 is a predictor for poor prognosis and regulates cell proliferation, migration and invasion in prostate cancer.

Dong L, Ding H, Li Y, Xue D, Li Z, Liu Y, Zhang T, Zhou J, Wang P. Dong L, et al. Int J Biol Macromol. 2019 Jan;121:200-206. doi: 10.1016/j.ijbiomac.2018.09.168. Epub 2018 Sep 26. Int J Biol Macromol. 2019. PMID: 30267820

9

MiR-515-5p acts as a tumor suppressor via targeting TRIP13 in prostate cancer.

Zhang X, Zhou J, Xue D, Li Z, Liu Y, Dong L. Zhang X, et al. Int J Biol Macromol. 2019 May 15;129:227-232. doi: 10.1016/j.ijbiomac.2019.01.127. Epub 2019 Jan 24. Int J Biol Macromol. 2019. PMID: 30685303

10

Anticancer evaluation of a novel dithiocarbamate hybrid as the tubulin polymerization inhibitor.

Liu J, Xue D, Zhu X, Yu L, Mao M, Liu Y. Liu J, et al. Invest New Drugs. 2020 Apr;38(2):525-532. doi: 10.1007/s10637-019-00799-z. Epub 2019 Jun 10. Invest New Drugs. 2020. PMID: 31183632

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters